Literature DB >> 18938091

Gene expression profiling of blood to predict the onset of leukemia.

Mario Medvedovic1, Danielle Halbleib, Marian L Miller, Kathy LaDow, Maureen A Sartor, Craig R Tomlinson.   

Abstract

No studies have tested the hypothesis that the onset of a disease can be predicted by gene expression profiling. The AKR/J mouse strain, which spontaneously develops acute T cell lymphatic leukemia, was used to implement a novel strategy to generate global gene expression profiles of WBCs at different time points. The experimental approach was bias free because it was unknown as to which individuals in the mouse population would eventually develop the disease. Our results suggest that profiling WBC gene expression may be an effective means for the very early diagnosis of disease in humans.

Entities:  

Mesh:

Year:  2008        PMID: 18938091      PMCID: PMC2633775          DOI: 10.1016/j.bcmd.2008.09.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  22 in total

1.  Hemopoietic and lymphoid organs in AKR/JY mice with thymic lymphoma.

Authors:  G V Karpova; T I Fomina; E V Abramova; N V Bel'skaya; E S Trofimova; V M Perel'muter
Journal:  Bull Exp Biol Med       Date:  2002-07       Impact factor: 0.804

2.  Microarray results improve significantly as hybridization approaches equilibrium.

Authors:  Maureen Sartor; Jennifer Schwanekamp; Danielle Halbleib; Ismail Mohamed; Saikumar Karyala; Mario Medvedovic; Craig R Tomlinson
Journal:  Biotechniques       Date:  2004-05       Impact factor: 1.993

3.  Bayesian mixture model based clustering of replicated microarray data.

Authors:  M Medvedovic; K Y Yeung; R E Bumgarner
Journal:  Bioinformatics       Date:  2004-02-10       Impact factor: 6.937

4.  Deregulation of the c-myc oncogene in virus-induced thymic lymphomas of AKR/J mice.

Authors:  A Reicin; J Q Yang; K B Marcu; E Fleissner; C F Koehne; P V O'Donnell
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

5.  Life span of specified-pathogen-free (MRC category 4) mice and rats.

Authors:  M F Festing; D K Blackmore
Journal:  Lab Anim       Date:  1971-10       Impact factor: 2.471

6.  Monoclonal AKR/J thymic leukemias contain multiple JH immunoglobulin gene rearrangements.

Authors:  W Herr; A P Perlmutter; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

7.  Free and integrated recombinant murine leukemia virus DNAs appear in preleukemic thymuses of AKR/J mice.

Authors:  W Herr; W Gilbert
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

8.  Expression of genes in the TGF-beta signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice.

Authors:  Junhai Guo; Maureen Sartor; Saikumar Karyala; Mario Medvedovic; Simone Kann; Alvaro Puga; Patrick Ryan; Craig R Tomlinson
Journal:  Toxicol Appl Pharmacol       Date:  2004-01-01       Impact factor: 4.219

Review 9.  Naturally occurring B-cell responses to breast cancer.

Authors:  Julia A Coronella-Wood; Evan M Hersh
Journal:  Cancer Immunol Immunother       Date:  2003-08-15       Impact factor: 6.968

10.  Different global gene expression profiles in benzo[a]pyrene- and dioxin-treated vascular smooth muscle cells of AHR-knockout and wild-type mice.

Authors:  Saikumar Karyala; Junhai Guo; Maureen Sartor; Mario Medvedovic; Simone Kann; Alvaro Puga; Patrick Ryan; Craig R Tomlinson
Journal:  Cardiovasc Toxicol       Date:  2004       Impact factor: 3.231

View more
  2 in total

1.  Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction.

Authors:  Hun-Jun Park; Ji Heon Noh; Jung Woo Eun; Yoon-Seok Koh; Suk Min Seo; Won Sang Park; Jung Young Lee; Kiyuk Chang; Ki Bae Seung; Pum-Joon Kim; Suk Woo Nam
Journal:  Oncotarget       Date:  2015-05-30

2.  Optimization of a high-throughput whole blood expression profiling methodology and its application to assess the pharmacodynamics of interferon (IFN) beta-1a or polyethylene glycol-conjugated IFN beta-1a in healthy clinical trial subjects.

Authors:  Normand E Allaire; Steven E Bushnell; Jadwiga Bienkowska; Graham Brock; John Carulli
Journal:  BMC Res Notes       Date:  2013-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.